Resistance to thapsigargin-induced intracellular calcium mobilization in a multidrug resistant tumour cell line

Molecular and Cellular Biochemistry

Volumn 252, Issue 1-2, 2003, Pages 109-116

  Wagner Souza, Karen ^a   Echevarria Lima, Juliana ^a   Rodrigues, Louise A P ^a   Reis, Marcelo ^a   Rumjanek, Vivian M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Ca2+; MDR; MDR modulatory agents; SERCA; Thapsigargin

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; CYCLOSPORIN A; GLYCOPROTEIN P; ISOENZYME; PROTEIN BCL 2; THAPSIGARGIN; VERAPAMIL; VINCRISTINE;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL CULTURE; CELL STRAIN K 562; CELL SURVIVAL; CELL TYPE; CELL VACUOLE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG SENSITIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MULTIDRUG RESISTANCE; TIME; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CALCIUM; CALCIUM-TRANSPORTING ATPASES; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; K562 CELLS; PROTO-ONCOGENE PROTEINS C-BCL-2; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; THAPSIGARGIN;

EID: 0141839813     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025586225941     Document Type: Article

References (48)

1. Gottesman MM, Pastan Y: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427, 1993
2. Juliano RL, Ling LA: Surface glycoprotein modulation drug permeability Chinese hamster ovary cell mutants. Biochem Biophys Acta 455: 152-162, 1976
3. Juranka PF, Zastawny RL, Ling V: P-glycoprotein: Multidrug-resistance and a superfamily of membrane-associated transport proteins. FASEB J 3: 2583-2592, 1989
4. Loo TW, Clarke DM: Molecular dissection of the human multidrug resistance P-glycoprotein. Biochem Cell Biol 77: 11-23, 1999
5. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV, Deeley RG: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654, 1992
6. Scheper RJ, Broxterman HJ, Scheffer GL, Kaaijk P, Dalton WS, Van-Heifningen THM, Van-Kalken CK, Slovak ML, De Vries EGE, Van Der Valk P, Meijer CJLM, Pinedo HM: Overexpression of a M(r) 110.000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 53: 1475-1479, 1993
7. Allikmets R, Schriml LM, Hutchinson A, Romano-Spica V, Dean M: A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res 58: 5337-5339, 1998
8. Miyake K, Mickley L, Litman T, Zhan Z, Robey R, Cristensen B, Brandi M, Greenberger L, Dean M, Fojo T, Bates SE: Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes. Cancer Res 59: 8-13, 1999
9. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y: Overcoming of vincristine resistance in P388 leukaemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41: 1967-1972, 1981
10. Slater LM, Sweet P, Stupecky M, Wetzel MW, Gupta S: Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma. Br J Cancer 54: 235-238, 1986
11. Twentyman PR: Cyclosporin as drug resistance modifiers. Biochem Pharmacol 43: 109-117, 1992
12. Yusa K, Tsuruo T: Reversal mechanism of multidrug by verapamil to P-glycoprotein on specific sites, and transport of verapamil outward across the plasma membrane of K562/ADM cells. Cancer Res 49: 5002-5006, 1989
13. Bates SE, Lee JS, Dickstein B, Spolyar M, Fojo AT: Differential modulation of P-glycoprotein transport by protein kinase inhibition. Biochemistry 32: 9156-9164, 1993
14. Holló Z, Homolya L, Hegedus T, Sarkadi B: Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells. FEBS Let 383: 99-104, 1996
15. de Bruin M, Miyake K, Litman T, Robey R, Bates SE: Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR. Cancer Let 146: 117-126, 1999
16. Diah SK, Smitherman PK, Aldridge J, Volk EL, Schneider E, Townsend AJ, Morrow CS: Resistance to mitoxantrone in multidrug-resistant MCF7 breast cancer cells: Evaluation of mitoxantrone transport and the role of multidrug resistance protein family proteins. Cancer Res 61: 5461-5467, 2001
17. Lowe SW, Ruley HE, Jacks T, Housman DE: p-53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967, 1993
18. Lenehan PF, Gutierrez PL, Wagner JL, Milak N, Fisher GR, Ross DD: Resistance to oxidants associated with elevated catalase activity in HL-60 leukaemia cells that overexpress multidrug-resistance protein does not contribute to the resistance to daunorrubicin manifested by these cells. Cancer Chemother Pharmacol 35: 377-386, 1995
19. Trindade GS, Capella MAM, Capella LS, Affonso-Mitidieri OR, Rumjanek VM: Differences in sensitivity to UVC, UVB and UVA radiation of a multidrug-resistant cell line overexpressing P-glycoprotein. Photochem Photobiol 69: 694-699, 1999
20. Volm M: Multidrug resistance and its reversal. Anticancer Res 18: 2905-2917, 1998
21. Campos L, Rouault JP, Sabido O, Orid P, Roubi, N, Vasselon C, Archimbaud E, Magaud J-M, Guyotat, D: High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 81: 3091-3096, 1993
22. Dole M, Nuñez G, Merchant AK, Maybaum J, Rode CK, Bloch CA, Casthe VP: Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res 54: 3253-3259, 1994
23. Van der Bliek AM, Meyers MB, Biedler JL, Hes E, Borst P: A 22-kd protein (sorcin/V19) encoded by an amplified gene in multidrug-resistant cells, is a homologous to the calcium-binding light chain of calpain. EMBO J 5: 3201-3208, 1986
24. Hamada H, Okochi E, Oh-hara T, Tsuruo T: Purification of the Mr 22,000 calcium-binding protein (sorcin) associated with multidrug resistance and its detection with monoclonal antibodies. Cancer Res 48: 173-178, 1988
25. Twentyman PR, Reeve JG, Koch G, Wright KA: Chemosensitisation by verapamil and cyclosporin A in mouse tumour cells expressing different levels of P-glycoprotein and CP22 (sorcin). Br J Cancer 62: 89-95, 1990
26. 2+ ATPase. Proc Natl Acad Sci USA 87: 2466-2470, 1990
27. 2+ transport ATPases by thapsigargin. J Biol Chem 267: 12606-12613, 1992
28. Putney JW: Capacitative calcium entry revisited. Cell Calcium 11: 611-624, 1990
29. 2+ transport ATPase and P-glycoprotein expression can mediate resistance to thapsigargin. J Biol Chem 269: 7976-7981, 1994
30. Chen JS, Agarwal N, Mehta K: Multidrug-resistant MCF-7 breast cancer cells contain deficient intracellular calcium pools. Breast Cancer Res Treat 71: 237-247, 2002
31. i homeostasis in MRP1 overexpression cells. FEBS Let 474: 107-110, 2000
32. 2+ fluxes. Proc Natl Acad Sci 91: 6569-6573, 1994
33. 2+. Oncogene 12: 2259-2266, 1996
34. He H, Lam M, McCormick TS, Distelhorst CW: Maintenance of calcium homeostasis in the endoplasmic reticulum by bcl-2. J Cell Biol 138: 1219-1228, 1997
35. Kuo TH, Kim HRC, Zhu L, Yu Y, Lin H-M, Tsang W: Modulation of endoplasmic reticulum calcium pump by Bcl-2. Oncogene 17: 1903-1910, 1998
36. 2+ transport ATPase in the development of thapsigargin resistance by Chinese hamster lung fibroblasts. J Biol Chem 270: 12140-12146, 1995
37. 2+ transport ATPase in thapsigargin-resistant hamster smooth muscle cells. Nucleic Acids Res 26: 4529-4537, 1998
38. 2+ ATPase function and their role in the cellular adaptative response to thapsigargin. Arch Biochem Biophys 362: 225-232, 1999
39. Rumjanek VM, Lucena M, Campos MM, Marques-Silva VM, Maia RC: Multidrug resistance in leukaemias: The problem and some approaches to its circumvention. Cien Cult 46: 63-69, 1994
40. Rumjanek VM, Trindade GS, Wagner-Souza K, Meletti-de-Oliveira MC, Marques-Santos LF, Maia RC, Capella MAM: Multidrug resistance in tumour cells: Characterisation of the multidrug resistant cell line K562-Lucena 1. An Acad Bras Ci 73: 57-69, 2001
41. Tsuruo T, Iida H, Ohkochi E, Tsukagoshi S, Sakurai Y: Establishment and properties of a vincristine-resistant human myelogenous leukemia K562. Jpn J Cancer Res 74: 751-758, 1983
42. Maia RC, Silva EAC, Harab RC, Lucena M, Pires V, Rumjanek VM: Sensitivity of vincristine-sensitive K562 and vincristine-resistant K562-Lucena I cells to anthracyclines and reversal of multidrug resistance. Brazilian J Med Biol Res 29: 467-472, 1996
43. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Meth 65: 55-63, 1983
44. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976
45. Nicolli A, Basso E, Petronilli V, Wenger RM, Bernardi P: Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, a cyclosporin A-sensitive channel. J Biol Chem 271: 2185-2192, 1996
46. Misra UK, Gawdi G, Pizzo SV: Cyclosporin A inhibits inositol 1,4,5-triphosphate binding to its receptor and release of calcium from intracellular stores in peritoneal macrophages. J Immunol 161: 6123-6127, 1998
47. 2+ transport ATPase in muscle and blood platelets by diacylglycerol analogues and cyclosporin A antagonism. Biochem J 327: 795-801, 1997
48. Orind M, Wagner-Souza K, Maia RC, Rumjanek VM: In: J.R. Sotelo, J.C. Benech (eds). Modulation of P-Glycoprotein on Tumour Cells in Calcium and Cellular Metabolism: Transport and Regulation. Plenun Publishing Co., 1997, pp 117-124